| Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease RH Haberman, R Herati, D Simon, M Samanovic, RB Blank, M Tuen, ... Annals of the rheumatic diseases 80 (10), 1339-1344, 2021 | 303 | 2021 |
| Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course K Tascilar, M Melikoglu, S Ugurlu, N Sut, E Caglar, H Yazici Rheumatology 53 (11), 2018-2022, 2014 | 255 | 2014 |
| SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases D Simon, K Tascilar, F Fagni, G Krönke, A Kleyer, C Meder, R Atreya, ... Annals of the rheumatic diseases 80 (10), 1312-1316, 2021 | 207 | 2021 |
| German mobile apps in rheumatology: review and analysis using the Mobile Application Rating Scale (MARS) J Knitza, K Tascilar, EM Messner, M Meyer, D Vossen, A Pulla, P Bosch, ... JMIR mHealth and uHealth 7 (8), e14991, 2019 | 162 | 2019 |
| Mobile health usage, preferences, barriers, and eHealth literacy in rheumatology: patient survey study J Knitza, D Simon, A Lambrecht, C Raab, K Tascilar, M Hagen, A Kleyer, ... JMIR mHealth and uHealth 8 (8), e19661, 2020 | 159 | 2020 |
| Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study G Hatemi, I Fresko, K Tascilar, H Yazici Arthritis & Rheumatism 58 (5), 1539-1545, 2008 | 141 | 2008 |
| The unique features of vasculitis in Behçet’s syndrome M Melikoglu, E Kural-Seyahi, K Tascilar, H Yazici Clinical reviews in allergy & immunology 35 (1), 40-46, 2008 | 115 | 2008 |
| The role of dietary fiber in rheumatoid arthritis patients: a feasibility study J Häger, H Bang, M Hagen, M Frech, P Träger, MV Sokolova, U Steffen, ... Nutrients 11 (10), 2392, 2019 | 112 | 2019 |
| Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion D Simon, K Tascilar, G Krönke, A Kleyer, MM Zaiss, F Heppt, C Meder, ... Nature communications 11 (1), 3774, 2020 | 109 | 2020 |
| COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses F Fagni, D Simon, K Tascilar, V Schoenau, M Sticherling, MF Neurath, ... The Lancet Rheumatology 3 (10), e724-e736, 2021 | 99 | 2021 |
| 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study C Bergmann, JHW Distler, C Treutlein, K Tascilar, AT Müller, A Atzinger, ... The Lancet Rheumatology 3 (3), e185-e194, 2021 | 92 | 2021 |
| Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study V Schönau, J Roth, K Tascilar, G Corte, B Manger, J Rech, D Schmidt, ... Rheumatology 60 (8), 3851-3861, 2021 | 64 | 2021 |
| Behçet syndrome manifestations and activity in the United States versus Turkey—a cross-sectional cohort comparison C Sibley, Y Yazici, K Tascilar, N Khan, Y Bata, H Yazici, ... The Journal of rheumatology 41 (7), 1379-1384, 2014 | 64 | 2014 |
| Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo … J Rech, K Tascilar, M Hagen, A Kleyer, B Manger, V Schoenau, ... The Lancet 403 (10429), 850-859, 2024 | 60 | 2024 |
| Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease D Simon, K Tascilar, F Fagni, K Schmidt, G Krönke, A Kleyer, A Ramming, ... Annals of the Rheumatic Diseases 81 (7), 1023-1027, 2022 | 57 | 2022 |
| Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial V Hamuryudan, G Hatemi, K Tascilar, N Sut, Y Ozyazgan, E Seyahi, C Mat, ... Rheumatology 49 (1), 173-177, 2010 | 57 | 2010 |
| Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs A Vodencarevic, K Tascilar, F Hartmann, M Reiser, AJ Hueber, J Haschka, ... Arthritis research & therapy 23, 1-8, 2021 | 54 | 2021 |
| Validation of risk scoring systems in ursodeoxycholic acid–treated patients with primary biliary cholangitis C Efe, K Taşçilar, I Henriksson, E Lytvyak, F Alalkim, H Trivedi, F Eren, ... Official journal of the American College of Gastroenterology| ACG 114 (7 …, 2019 | 53 | 2019 |
| Effects of conventional uric acid–lowering therapy on monosodium urate crystal deposits H Ellmann, S Bayat, E Araujo, B Manger, A Kleyer, A Cavallaro, M Lell, ... Arthritis & Rheumatology 72 (1), 150-156, 2020 | 52 | 2020 |
| Secretory Carcinoma of the BreastCase Report and Review of the Literature M Ozguroglu, K Tascılar, S Ilvan, G Soybir, V Celik Oncology 68 (2-3), 263-268, 2005 | 52 | 2005 |
